Postoperative antimicrobials after lung transplantation and the development of multidrug‐resistant bacterial and Clostridium difficile infections: an analysis of 500 non‐cystic fibrosis lung transplant patients
Clinical Transplantation2016Vol. 30(7), pp. 767–773
Citations Over Time
Alexandra R. Whiddon, Kyle L. Dawson, Amaris Fuentes, Katherine K. Perez, L. E. Peterson, Thomas Kaleekal
Abstract
One-third (34%) of non-CF lung transplants develop MDR infections and 6% develop CDI within 90 d of postoperative antimicrobials. The duration of Gram-positive antimicrobials may increase the risk of MDR/CDI, while early transfer from the ICU may have a protective effect.
Related Papers
- → Fifteen years of lung transplantation (LTx) in patients with cystic fibrosis (CF): the Zurich experience(2008)
- → 68 The physiological state of Pseudomonas aeruginosa populations in lungs of Cystic Fibrosis (CF) patients(2006)
- → 40 Longitudinal values of sweat chloride concentration among infants identified by cystic fibrosis (CF) newborn screening (NBS) in California(2013)
- → WS18.6 Pregnancy after lung transplantation in cystic fibrosis patients(2018)
- → P058 Follow-up before and after lung transplantation for cystic fibrosis: state of the French practices between 2011 and 2017 based on the French Registry(2020)